Drugs / JW0106
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06816719 | Sep → Nov 2024 | — | JW Pharmaceutical | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | JW0106 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06816719 ↗ |
| Route | Oral | “Administration orally with 150 mL of water under fasting conditions” NCT06816719 ↗ |